- Results suggest that mesothelin-targeted TriKE can work alongside current standard of care and provide benefit even in the hypoxic environment of a solid tumor
PR Newswire
BRISBANE, Calif., March 9, 2022
PR Newswire
BRISBANE, Calif., March 9, 2022
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey